Clinical trial

Haploidentical Stem Cell Transplant for Patients With Sickle Cell Disease and…

NCT00152113 · St. Jude Children's Research Hospital, Other · Completed

Key facts

NCT number NCT00152113
Title Haploidentical Stem Cell Transplant for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial Ultrasound
Official title Hematopoietic Stem Cell Transplantation for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial Doppler Ultrasound Using Reduced-Intensity Conditioning and T-Cell Depleted HSC From Partially Matched Family Donors
Lead sponsor St. Jude Children's Research Hospital, Other
Status Completed
Phase Phase 1
Study type Interventional
Conditions Sickle Cell Disease
Intervention type Device, Drug, Procedure
Interventions Hematopoietic Stem Cell Transplantation, CliniMACS, See intervention description
Enrollment 5
Start date Apr 1, 2005
Primary completion Dec 1, 2008
Completion Jan 1, 2009
First posted Sep 9, 2005
Last update posted Apr 26, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies